Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
Merck expects cancer therapy Keytruda to be part of government price setting in 2026
Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government ...
24/7 Wall St. on MSN1d
HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?
The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO) was ...
Novo Nordisk A/S (NVO): Is It The Most Oversold Healthcare Stock to Buy Now?
We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...
Novo Nordisk A/S (NVO): Among Renaissance Technologies Portfolio’s Top Stock Picks
We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...
STAT5h
A TikTok video spurs alarm about Medicare coverage for telehealth
Ro Khanna (D-Calif.) posted a video on TikTok informing his 400,000 followers of “breaking news” that “the Trump ...
Insider Monkey4d
Novo Nordisk A/S (NVO): Is It The Most Oversold Healthcare Stock to Buy Now?
The Centers for Medicare & Medicaid Services reported ... beating its benchmark by 150 percentage points (see more details here). Novo Nordisk A/S (NYSE:NVO) is a global healthcare company ...
NBC Chicago4d
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Novo Nordisk's stock closed about 5% higher on ... weight loss drugs such as Wegovy are not currently covered by Medicare and other insurance. Don't expect a 20% S&P 500 three-peat this year ...